Fair Value Calculator Fair Value Calculator
EN DE

ROOPAIND (ROOPAIND) Fair Value & Analysis

IN · Market cap ₹393M

R ROOPAIND ROOPAIND · BSE
Price₹49.99
Fair Value₹5.01
Upside-90.0%
Quality53/100
Watch ROOPAIND for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹2.06 – ₹7.03

Fair value as of: Jul 5, 2026

From 24 valuation models · updated today

Share price −4.7% over the past month.

Price vs Fair Value (12 months)

₹61.70 ₹39.19 Fair Value ₹5.01 Jul 2025 Jul 2026

12‑month range ₹39.19 – ₹61.70 · fair‑value band ₹2.06 – ₹7.03 · the ₹49.99 price screens above the ₹5.01 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

ROOPAIND (ROOPAIND) currently trades at ₹49.99, while our model-based Fair Value estimate is ₹5.01 — implying the stock looks roughly 90.0% overvalued today. We read business quality at 53/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, ROOPAIND generated revenue of ₹1.3B at a net margin of 0.1%. Revenue grew 3.4% year over year. It earns a return on equity of 0.5%. Net debt stands at ₹310M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹2.06 (bear case) to ₹7.03 (bull case); at ₹49.99, the current price sits above that range. The share trades about 21% below its 52-week high and 31% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹1.3B
Revenue growth (YoY) +3.4%
Net margin 0.1%
Return on equity 0.5%
Free cash flow ₹41.6M FY2026
P/E ratio 384.5
More key figures
Operating margin 9.9%
EPS (TTM) ₹0.1300
EPS growth (YoY) +1.0%
Net debt ₹310M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

ROOPAIND reported revenue of ₹1.3B in FY2026 versus ₹512M in FY2022, a compound +25.6%/yr. Reported net income was ₹831K in FY2026, compounding −46.5%/yr from FY2022.

Revenue +25.6%/yr
FY22 ₹512M
FY23 ₹762M
FY24 ₹704M
FY25 ₹1.2B
FY26 ₹1.3B
Net income −46.5%/yr
FY22 ₹10.2M
FY23 ₹13.5M
FY24 ₹15.2M
FY25 ₹20.3M
FY26 ₹831K

Is ROOPAIND fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "ROOPAIND Fair Value". https://www.fairvalue-calculator.com/stock/ROOPAIND

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is ROOPAIND (ROOPAIND) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹5.01 versus a price of ₹49.99 — about −90% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ROOPAIND?
Our model-based fair value for ROOPAIND is ₹5.01 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹49.99.
What is the quality score of ROOPAIND?
ROOPAIND has a Quality Score of 53/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of ROOPAIND (ROOPAIND)?
ROOPAIND reported trailing-twelve-month revenue of about ₹1.3B (latest available figure, as of Jul 5, 2026).
What is the net profit margin of ROOPAIND?
The net profit margin of ROOPAIND is about 0.1%, meaning it keeps roughly 0.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.